These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results. Pizzocaro G; Salvioni R; Piva L; Faustini M; Nicolai N; Gianni L Ann Oncol; 1992 Mar; 3(3):211-6. PubMed ID: 1316779 [TBL] [Abstract][Full Text] [Related]
6. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89]. Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864 [TBL] [Abstract][Full Text] [Related]
7. Treatment Results of Extracranial Malignant Germ Cell Tumor with Regimens of Cisplatin, Vinblastine, Bleomycin or Carboplatin, Etoposide, and Bleomycin with Special Emphasis on the Sites of Vagina and Testis. Hou JY; Liu HC; Yeh TC; Sheu JC; Chen KH; Chang CY; Liang DC Pediatr Neonatol; 2015 Oct; 56(5):301-6. PubMed ID: 25769700 [TBL] [Abstract][Full Text] [Related]
8. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy. Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521 [TBL] [Abstract][Full Text] [Related]
9. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial. Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363 [TBL] [Abstract][Full Text] [Related]
10. Cisplatin and etoposide in childhood germ cell tumor: brazilian pediatric oncology society protocol GCT-91. Lopes LF; Macedo CR; Pontes EM; Dos Santos Aguiar S; Mastellaro MJ; Melaragno R; Vianna SM; Lopes PA; Mendonça N; de Assis Almeida MT; Sonaglio V; Ribeiro KB; Santana VM; Schneider DT; de Camargo B J Clin Oncol; 2009 Mar; 27(8):1297-303. PubMed ID: 19164215 [TBL] [Abstract][Full Text] [Related]
11. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C; J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987 [TBL] [Abstract][Full Text] [Related]
12. Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group. Shaikh F; Cullen JW; Olson TA; Pashankar F; Malogolowkin MH; Amatruda JF; Villaluna D; Krailo M; Billmire DF; Rescorla FJ; Egler RA; Dicken BJ; Ross JH; Schlatter M; Rodriguez-Galindo C; Frazier AL J Clin Oncol; 2017 Apr; 35(11):1203-1210. PubMed ID: 28240974 [TBL] [Abstract][Full Text] [Related]
13. Testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients. Göbel U; Calaminus G; Haas R; Teske C; Schönberger S; Schneider DT; Leuschner I; Harms D Klin Padiatr; 2014 Nov; 226(6-7):316-22. PubMed ID: 25431864 [TBL] [Abstract][Full Text] [Related]
14. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors. Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. Bajorin DF; Sarosdy MF; Pfister DG; Mazumdar M; Motzer RJ; Scher HI; Geller NL; Fair WR; Herr H; Sogani P J Clin Oncol; 1993 Apr; 11(4):598-606. PubMed ID: 8386751 [TBL] [Abstract][Full Text] [Related]
16. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891. Rogers PC; Olson TA; Cullen JW; Billmire DF; Marina N; Rescorla F; Davis MM; London WB; Lauer SJ; Giller RH; Cushing B; ; J Clin Oncol; 2004 Sep; 22(17):3563-9. PubMed ID: 15337806 [TBL] [Abstract][Full Text] [Related]
17. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases]. Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study]. Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267 [TBL] [Abstract][Full Text] [Related]
19. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group. Hartmann JT; Gauler T; Metzner B; Gerl A; Casper J; Rick O; Horger M; Schleicher J; Derigs G; Mayer-Steinacker R; Beyer J; Kuczyk MA; Bokemeyer C; J Clin Oncol; 2007 Dec; 25(36):5742-7. PubMed ID: 18089869 [TBL] [Abstract][Full Text] [Related]
20. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996]. Fléchon A; Biron P; Philip I; Blay JY; Droz JP Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]